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Purpose: We analyzed the surgical and functional outcomes of 100 consecutive laparo-
scopic radical prostatectomies (LRP) performed by a single surgeon. 
Materials and Methods: Between October 2007 and May 2010, a total of 100 consecutive 
patients underwent LRP for prostate cancer at our institution. We retrospectively re-
viewed the medical records of these patients to determine surgical and functional results. 
We compared surgical and functional outcomes between three groups divided on the basis 
of operation period (Group 1; first 40 cases; Group 2; next 30 cases; Group 3; last 30 cases). 
Results: The operative time decreased significantly as the surgeon’s experience in-
creased over time (P＜0.01). The learning curve for operative time was surpassed after 
approximately 40 cases. The overall positive surgical margin (PSM) rate was 17.5% 
in Group 1, 16.7% in Group 2, and 10% in Group 3. For organ-confined disease, the PSM 
rate was 2.5%, 6.7%, and 3.3% in Groups 1, 2, and 3, respectively. The continence rate 
(absence of a pad) was 73.2% and the social continence rate was 94.7% at 12 months 
after surgery. There was a significant difference in continence (absence of pad) between 
the early (Group 1) and late group (Group 3) at 1, 3, and 6 months (P＜0.0001). The 
continence rate was not affected by whether the pubic bone-anchoring procedure or the 
Rocco suture method was used. The overall potency rate was 16.7% and 48.6% at 6 and 
12 months, respectively. For bilateral nerve-sparing cases, the potency rate was 20% 
and 57.1% at 6 and 12 months, respectively.
Conclusions: Our surgical and functional outcomes indicate that even in this ‘robotic
era’, LRP is still an attractive treatment option for patients with localized prostate can-
cer, especially in areas with limited access to surgical robots.
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INTRODUCTION 
Laparoscopic radical prostatectomy (LRP) is known to be 
a technically challenging procedure. Improvements in lap-
aroscopic equipment and techniques have led to lower mor-
bidity, decreased postoperative pain, and a reduced length 
of hospital stay compared with open surgery. Furthermore, 
these improvements have yielded functional outcomes 
comparable to or better than those obtained with standard 
radical retropubic prostatectomy (RRP) [1-4]. However, 
laparoscopic surgery usually requires acquisition of new 
anatomical perspectives, excellent hand-to-eye coordina-
tion, and great manual dexterity. All these restrictions con-
tribute to the steep learning curve of laparoscopic surgery 
[5]. Because of these technical difficulties associated with 
LRP, robot-assisted laparoscopic prostatectomy (RALP) 
has been used for prostate cancer treatment. However, the 
Korean national medical insurance system does not re-Korean J Urol 2011;52:517-523
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TABLE 1. Preoperative patient characteristics
Characteristic Value Range
No. of patients
Mean age (yr)
Mean PSA (ng/ml)
Mean BMI (kg/m
2)
Median preop. Gleason score
Clinical stage, No.
    T1
    T2
    T3a
    T3b
Mean prostate weight (g)
100
  66
         8.01
       24.12
    6
  23
  49
  22
    6
      37.7
28-77
  0.08-41.26
17.21-31.42
  4-10
17-80
PSA: prostate-specific antigen, BMI: body mass index
TABLE 2. Intraoperative and postoperative patient character-
istics
Characteristic Value Range
Median pathological Gleason score
pT stage, No.
    T2
    T3a
    T3b
    T4
PLND, No.
Positive lymph nodes, No.
Positive surgical margin (%)
NVB saving, No.
    Unilateral
    Bilateral
Mean operative time (min)
Estimated blood loss (ml)
Mean follow-up, months
  7
63
27
  9
  1
32
  2
15
54
19
36
 210.0
 201.9
   13.9
6-9
74-380
50-600
2-28
PLND: pelvic lymph node dissection, NVB: neurovascular bundle
imburse surgeons for the cost of RALP (which is 5-6 times 
the cost of LRP). LRP therefore remains a viable treatment 
option for patients with localized prostate cancer in Korea. 
The aim of this study was to report the surgical and func-
tional outcomes of 100 consecutive patients who under-
went LRP by a single surgeon at our institution.
MATERIALS AND METHODS
Between October 2007 and May 2010, a total of 100 consec-
utive patients underwent LRP for prostate cancer at our 
institution. All procedures were performed by a single sur-
geon who was fellowship trained in laparoscopic urologic 
surgery. Eighty-nine patients were operated on by using 
a transperitoneal approach, whereas the remaining 11 pa-
tients were operated on by using an extraperitoneal ap-
proach according to the surgeon’s preference.
All patients had prostate cancer as diagnosed by trans-
rectal ultrasound-guided prostate needle biopsies. For 
work-up staging, a whole-body bone scan and prostate 
magnetic resonance imaging (MRI) were performed. The 
TNM 2002 classification was used to stage the operative 
specimens. Data including preoperative clinical and bio-
logical characteristics, patient demographics, surgical da-
ta, pathological features, and postoperative variables were 
collected retrospectively from a database. The operative 
time was defined as the time between CO2 gas on and off, 
and the estimated blood loss (EBL) was calculated by the 
anesthesiologist. Urinary continence was defined as the 
absence of a pad, and we also conducted an analysis of social 
continence, which was defined as the use of either no pad 
or one security pad daily. Potency was defined as the ability 
to achieve an erection sufficient for penetration with or 
without the use of phophodiesterase-5 enzyme inhibitor. 
Postoperative potency was evaluated in all patients who 
were sexually active and potent preoperatively and who 
had undergone a unilateral or bilateral nerve-sparing 
operation. The percentage of patients who were continent 
and the potency rate were evaluated at 1, 3, 6, and 12 
months after surgery. Biochemical recurrence was defined 
as a serum PSA level ≥0.2 ng/ml in at least three consec-
utive measurements. The surgical techniques that we used 
are described in detail in a previous publication [6]. 
1. Statistical analysis
Patient characteristics were calculated as means or me-
dians and percentages for the overall population and proce-
dural period. All data were analyzed by using SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA) by applying Student’s 
t-test, the Chi-square test, Fisher’s exact test, the 
Mann-Whitney test, the Kruskal-Wallis test, Spearman’s 
rank correlation test, the log-linear model, and censored 
data analysis where appropriate.
RESULTS
The patients’ characteristics are listed in Table 1, 2. 
Briefly, the mean patient age was 66 years (range, 28-77 
years), the mean PSA level was 8.01 ng/ml, and the dis-
tribution of clinical stages was as follows: 23% T1, 49% T2, 
22% T3a, and 6% T3b.
The overall mean operative time was 210 minutes 
(range, 74-380 minutes), and the operation time decreased 
as the number of cases increased (log-linear model, 
Spearman’s rho −0.491, p＜0.01) (Fig. 1A). According to 
the minimum p-value approach, there was a significant dif-
ference in the operative time cutoff at 40 cases; after 40 cas-
es, the mean operative time reached a plateau. Thus, the 
surgeon’s learning curve with regard to operative time was 
overcome after approximately 40 cases. The overall mean 
estimated blood loss was 201.9 ml (range, 50-600 ml). 
However, there was no significant correlation between 
EBL and the case number (log-linear model, Spearman’s 
rho −0.237, p=0.05) (Fig. 1B).
We divided the patients into three groups (first 40 cases 
vs. next 30 cases vs. last 30 cases). The early group (Group Korean J Urol 2011;52:517-523
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TABLE 3. Comparisons of perioperative parameters according to groups divided on the basis of the operation period
Characteristic Group 1 Group 2 Group 3 p-value
No. of patients
Mean age (yr)
Mean PSA (ng/ml)
Mean BMI (kg/m
2)
Preop. Gleason score (median)
Clinical stage, No.
    T1
    T2
    T3a
    T3b
Prostate, weight (g)
Pathological Gleason score (median)
pT stage, No.
    T2
    T3a
    T3b
    T4
PSM, No. (%)
    T2c
    T3a
    T3b
    T4
NVB saving No. (%)
    Unilat.
     Bilat.
Foley indwelling days (mean)
Mean OP time (min)
Median (Q1, Q3) time (min)
Mean EBL(ml)
Median (Q1,Q3) EBL (ml)
PLND, No.
40
   64.4
       8.60
   24.8
     6.5
  6
22
  9
  3
   39.3
  7
25
12
  2
  1
     7 (17.5)
  1
  5
  0
  1
   23 (57.5)
  9
14
   10.9
236.8
       230 (210,255)
250
       200 (150,300)
16
  30
     67.5
         8.76
     24.1
    7
    7
  15
    7
    1
     38.2
    7
  18
    7
    5
    0
        5 (16.7)
    2
    2
    1
    0
      14 (46.7)
    5
    9
       8.9
   198.3
       197.5 (170,220)
147
          100 (100,200)
    8
30
   67.7
       6.48
   23.2
  6
10
12
  6
  2
   35.1
  7
20
  8
  2
  0
  3 (10)
  1
  0
  2
  0
18 (60)
  5
13
     6.7
 186.1
       190 (170,205)
192
       170 (150,200)
  8
0.163
a
0.394
a
0.055
b
0.578
a
0.688
c
0.581
a
0.111
a
0.648
d
0.774
d
0.536
c
＜.0001
a
＜.0001
e
0.002
e
PSM: positive surgical margin, NVB: neurovascular bundle, PLND: pelvic lymph node dissection, Q1: first quartile, Q3: third quartile, 
(Q1, Q3): inter quartile range, 
a: Mann-Whitney test, 
b: student’s t-test, 
c: chi-square test, 
d: fisher’s exact test, 
e: kruskal-wallis test
FIG. 1. Correlation between operative time and case number (A), and between EBL and case Number (B).
1) consisted of the first 40 cases; this number of cases was 
chosen because after the 40th case, the learning curve in 
terms of operative time was surpassed. The middle and late 
groups (Groups 2, 3) constituted the next 30 cases in 
succession. Patient characteristics, the clinical stage, and 
pathological outcomes were comparable among the three Korean J Urol 2011;52:517-523
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TABLE 4. Comparison of the continence rate of groups 1, 2, 3 at 1, 3, and 6 months by censored data analysis
A. Continence rate - Absence of pad
Group 1 vs. Group 2 Group 1 vs. Group 3 Group 2 vs. Group 3
Cont. rate %
1 month
3 months
6 months
G 1
11.6
36.9
65.6
G2
  6.7
23.3
54.7
p-value
1
0.071
0.547
G 1
11.6
36.9
65.6
G 3
16.7
56.4
78.2
p-value
＜.0001
＜.0001
＜.0001
G 2
  6.7
23.3
54.7
G 3
16.7
56.4
78.2
p-value
＜.0001
＜.0001
0.088
B. Continence rate - Social continence: pad ≤1/day.
Group 1 vs. Group 2 Group 1 vs. Group 3 Group 2 vs. Group 3
Cont. rate %
1 month
3 months
6 months
G 1
47.2
80.6
91.7
G2
50.0
67.0
93.3
p-value
1
1
1
G 1
47.2
80.6
91.7
G 3
70.0
98.5
95.0
p-value
1
0.516
1
G 2
50.0
67.0
93.3
G 3
70.0
98.5
95.0
p-value
0.957
0.035
1
Cont.: continence
FIG. 2. Recovery of continence according to postoperative period.
groups. The positive surgical margin (PSM) rate was 6.3% 
(4/63) in pT2 and 27.8% (10/36) in pT3 tumors. An analysis 
of the overall PSM rate by group revealed that the PSM rate 
was 17.5% (7/40) in Group 1, 16.7% (5/30) in Group 2, and 
10% (3/30) in Group 3 (Table 3). For organ-confined disease, 
the PSM rate was 2.5% (1/40) in Group 1, 6.7% (2/30) in 
Group 2, and 3.3% (1/30) in Group 3.
Of the 99 patients, 9 (9.1%) had a PSA level ≥0.2 ng/ml 
at their postoperative 3-month visit. Among 9 patients, 6 
patients underwent adjuvant androgen deprivation ther-
apy, 2 patients missed the follow-up, and 1 patient experi-
enced a spontaneously decreased PSA level ＜0.2 ng/ml be-
fore 12 months postoperatively. Of the 100 patients, bio-
chemical recurrence occurred in 7 patients during the fol-
low-up period. These seven patients underwent salvage ra-
diation therapy (one patient) or androgen deprivation ther-
apy (six patients).
Two intraoperative and two postoperative complications 
required intervention. Intraoperative complications oc-
curred only in Group 1 and consisted of a ureter injury and 
a rectal injury that resulted in a recto-urethral fistula. For 
the former, a stented ureteroneocystostomy was per-
formed laparoscopically. For the latter, a temporary divert-
ing sigmoidostomy and fistula repair were performed.
The postoperative complications that occurred in 
Groups 2 and 3 involved an anastomosis site stricture and 
inguinal hernia. These patients were treated by sound and 
herniorrhaphy.
Continence (absence of a pad) was achieved in 73.2% of 
patients at 12 months after surgery. The social continence 
(0-1 pads per day) rate was 94.7% at 12 months after sur-
gery (Fig. 2). The continence rate (absence of a pad) at 1, 
3, and 6 months was 11.6%, 36.9%, and 65.6%, respectively, 
in Group 1 and 16.7%, 56.4%, and 78.2%, respectively, in 
Group 3, which was a significant difference (adjusted p-val-
ue for 1, 3, and 6 months, p＜0.0001) (Table 4A).
However, there was no significant difference in the social 
continence rate at 1, 3, and 6 months among the three 
groups (Table 4B). In terms of surgical technique, there was 
no significant difference in the continence rate related to 
the use of the pubic bone anchoring procedure or a Rocco 
suture (Table 5). Of 100 patients, artificial urethral sphinc-
ter insertion had to be performed in two patients because 
of post-prostatectomy incontinence.
The overall potency rate was 16.7% and 48.6% at 6 and 
12 months, respectively. This rate reached 20% at 6 months 
and 57.1% at 12 months for bilateral nerve-sparing cases, 
compared with 11.1% and 35.7% for unilateral nerve-spar-
ing cases, respectively (Table 6).
DISCUSSION
A recent study reported that a surgeon’s experience with 
radical prostatectomy can have a great impact on clinical 
outcomes and complications [7]. Historically, the mastery 
of LRP has required a steep learning curve, with even expe-
rienced laparoscopic surgeons requiring nearly 60 cases to 
obtain proficiency [8]. The improvement in LRP techniques Korean J Urol 2011;52:517-523
Outcomes of LRP Performed by a Single Surgeon 521
TABLE 5. Differences in the continence rate according to whether pubic bone anchoring or Rocco suturing were used
Pad=0 (Sling) Pad=0 (Rocco)
Period Sling (＋)S l i n g  ( −) p-value Rocco (−) Rocco (＋)p - v a l u e
1 month
3 months
6 months
12 months
  7.7
23.1
56.8
70.4
16.1
52.0
55.6
33.3
0.263
b
  0.0591
a
0.167
b
0.298
b
  8.2
34.6
64.0
74.5
14.9
42.9
60.6
66.7
0.294
a
0.692
a
0.849
a
0.510
a
a: chi-square test, 
b: Fisher’s exact test
TABLE 6. Recovery of potency according to postoperative period
Potency Unilateral Bilateral Total
3 months (%)
6 months (%)
12 months (%)
0/18 (0)
   2/18 (11.1)
   5/14 (35.7)
 3/32 (9.4)
6/30 (20)
 12/21 (57.1)
3/50 (6)
  8/48 (16.7)
17/35 (48.6)
has decreased the length of the learning curve for LRP for 
laparoscopic-naïve surgeons [9]. For example, Guillon-
neau et al reported operative times of 4.6 hours for their 
first 50 cases, 4.0 hours for the next 50 cases, and 3.4 hours 
for their most recent 140 cases [8]. Ghavamian et al re-
ported an operative time of 6.8 hours (411 min) for their first 
10 cases and 3.3 hours (195 min) for their last 20 cases [10]; 
the learning curve for operative time was overcome after 
35 cases. The operative time of our first 40 cases was 236.8 
min compared with 186.1 min for the last 30 cases. 
Similarly, the learning curve in terms of operative time was 
overcome after approximately 40 cases; the mean oper-
ative times reached a plateau after that number.
Low blood loss is often considered one of the main advan-
tages of laparoscopic surgery. In previous studies, the 
mean EBL for RRP ranged from 820 to 1,550 cc [11,12], 
whereas that for LRP was 380 to 800 cc [11,13] and that for 
RALP was 206 to 300 cc [14-16]. The overall EBL in our 
study was 202 cc, and there were no significant correlations 
between EBL and the number of cases. Rozet et al com-
pared the clinical outcomes of LRP and RALP. They demon-
strated that the mean EBL was 234 ml during RALP and 
482 ml during LRP and that the mean operative time was 
182 min for RALP and 234 min for LRP [17], consistent with 
our LRP results.   
Ahlering et al reported a PSM rate of 27.3% for or-
gan-confined disease after their first 50 robotic cases, but 
this decreased to 4.7% after experience with 150 cases [18]. 
Our PSM rate was 11% for organ-confined disease after our 
initial 31 cases [19], but this number decreased to 6.3% af-
ter 100 consecutive cases.
In the 56 patients followed up for 12 months, 73.2% of the 
patients were completely continent and 94.7% of the pa-
tients were socially continent. These figures are similar to 
those reported in previous RALP studies; a 73% continence 
rate was reported by Guillonneau et al (1999), whereas sev-
eral groups have reported social continence rates of 90% to 
95% after RALP [20-23]. In previous studies and our study, 
urinary continence and erectile function were subjectively 
determined by surgeon interviews and patient reports at 
postoperative visits [24-26]. However, to more objectively 
evaluate continence, we analyzed both pad-free continence 
and social continence (0-1 pads per day). We found a 
marked difference between pad-free and social continence. 
We therefore recommend that the absence of a pad should 
be taken into consideration when evaluating urinary con-
tinence after a prostatectomy. 
According to our results, there was no significant differ-
ence in the recovery of continence whether a pubic bone an-
choring procedure or a Rocco suture was used, but there 
was a significant improvement in the continence rate in the 
latest group at 1, 3, and 6 months compared with the ear-
liest group. More meticulous and precise dissection of the 
prostatic apex and urethra may occur as the surgeon’s ex-
perience increases; we attribute the improvement in the 
continence rate of the latest group to this improvement.
Preservation of the neurovascular bundles in both retro-
pubic and laparoscopic prostatectomy has been demon-
strated to significantly improve potency outcomes [27,28]. 
Herrmann et al reported a potency rate of 21% to 90% after 
RRP, 39% to 72% after LRP, and 36% to 84% after RALP 
[29]. Our potency rate was 57.1% in the bilateral neuro-
vascular bundle-saved group.
As we stated above, our surgical and functional LRP out-
comes are comparable with those reported for previous 
RALP series. In our opinion, the greatest disadvantage of 
RALP is the high cost associated with setting up and main-
taining a robotic system. Furthermore, the volume-out-
come relationship is an issue; smaller centers have found 
it difficult to overcome their learning curves. For this rea-
son, we think that even in the “robotic era,” in the case of 
surgeons who have some experience with laparoscopic sur-
gery, the LRP technique might be offered to patients with 
prostate cancer as a viable, alternative treatment option, 
especially in areas with limited access to surgical robots.
One limitation of this study was the relatively small ser-
ies (100 patients) and short follow-up duration (mean 13.9 
months). The methods we used to evaluate functional out-
comes were another limitation; patient and surgeon per-
ceptions of functional impairment after radical prostatec-
tomy can differ by up to 80% for urinary function and by 
up to 50% for sexual function [30]. This study was retro-Korean J Urol 2011;52:517-523
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spective in nature and was limited to procedures performed 
by a single surgeon. Our LRP and previous RALP cohorts 
were also not identical. Therefore, we cannot generalize 
our results because of subjective variables such as the sur-
geon’s experience. 
CONCLUSIONS 
Laparoscopic radical prostatectomy performed by a single 
surgeon yielded acceptable perioperative and early post-
operative outcomes in a series of 100 patients with prostate 
cancer.
There was no significant difference in the recovery of con-
tinence whether a pubic bone anchoring procedure or a 
Rocco suture was used, but there was a significant improve-
ment in the continence rate in the latest group at 1, 3, and 
6 months compared with the earliest group. Our surgical 
and functional outcomes, especially with regard to con-
tinence, indicate that LRP remains an attractive treat-
ment option for patients with localized prostate cancer, 
even in the robotic era. 
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